Search results for: Determining Value

Themes

…value they assign to those outcomes, and how best to incorporate these outcomes and values in decision-making. Policy, Organisation and Incentives in Health Systems Development of effective health system policy…

Just Published: Systematic Review of PRO Use in Paediatric Populations with Vaccine-Preventable Infectious Diseases

15 December 2015

…The results of a systematic review on the use of patient reported outcomes (PROs) in paediatric populations with infectious diseases were recently published in Value in Health.  The Patient-Reported Outcomes…

Using QALYs in Cancer: Review of the Methodological Limitations

1 October 2010

…basis of health state valuations also matters. Using the general public to value health states may overvalue interventions aimed at achieving perfect health and undervalue those aimed at prolonging life…

OHE at the Health Economists’ Study Group (HESG) Meeting, Manchester 2016

4 January 2016

…multinational trials should report country-specific cost-effectiveness results, yet typically these country specific results are only used to assess the between-location variability.  We use value of information (VOI) analysis (assuming a…

Seminar at Glasgow Caledonian University: Local Health Care Expenditure Plans and Their Opportunity Costs

11 January 2016

OHE’s Sarah Karlsberg Schaffer presented at the Glasgow Health Economics Seminar Series the results of a paper on the value of the cost-effectiveness threshold in Scotland. In November, OHE’s Sarah…

A Spotlight on Haemophilia Therapies

3 October 2024

…Share this: Download publication This progress has been exemplified in the context of haemophilia, where iterative and incremental innovation has added significant value for patients and health systems. New treatments…

OHE Welcomes Patrick Holmes to the Board of Trustees

28 March 2022

…Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Value and Access and Pandemic Preparedness Working Groups, Innovation and Value Initiative (IVI) Scientific Advisory Panel and the European Federation of Pharmaceutical Industries…

NICE’s severity modifier: a step in the right direction, but still a long way to go

23 March 2022

…the task – but how will this be translated into categories based on discounted scores? And how will it be determined that the general population actually agree with the value…

Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity

1 December 2012

The UK Government is proposing to include “burden of illness” criteria in its scheme for value based pricing of branded medicines, potentially according higher rewards to medicines that treat more…